Mai-Jun - Sociedade Brasileira de Oftalmologia

More documents

Recommendations

Info

Características e deficiências dos programas de pós-graduação em oftalmologia no Brasil segundo pós-graduandos participantes 179satisfatória, no entanto nem todas são presenciais emtodos os turnos. A maioria dos pós-graduandos sugeriuum aumento do volume cirúrgico e do número de cirurgiasexperimentais, melhoria na infraestrutura, dos equipamentose instalações físicas.Este estudo é de grande impacto na área do ensinoe pode contribuir para a formação de novas políticasde ensino na sociedade brasileira de oftalmologia.REFERÊNCIAS1. Truhlsen SM. The American Academy of Ophthalmology. In:Albert DM, Edward DD, editors. The history of ophthalmology.Cambridge: Blackwell Science; 1996. p.323-58.2. Pankratz MJ, Helveston EM. Ophthalmology. The resident’sperspective. Arch Ophthalmol. 1992;110(1):37-43.3. Liesegang TJ, Hoskins HD Jr, Albert DM, O’Day DM, SpiveyBE, Sadun AA, et al. Ophthalmic education: where have wecome from, and where are we going? Am J Ophthalmol.2003;136(1):114-21. Review.4. Lee AG, Beaver HA, Greenlee E, Oetting TA, Boldt HC,Olson R, et al. Teaching and assessing systems-based competencyin ophthalmology residency training programs. SurvOphthalmol. 2007;52(6):680-9. Review.5. McDonnell PJ, Kirwan TJ, Brinton GS, Golnik KC, MelendezRF, Parke DW 2nd, et al. Perceptions of recent ophthalmologyresidency graduates regarding preparation for practice.Ophthalmology. 2007;114(2):387-91.6. Trobe JD, Fraunfelder F, Jones DB, Kearns TP, Kinder RS,Milder B, et al. Monitoring ophthalmology graduate education.The Residency Review Committee. Arch Ophthalmol.1982;100(1):67-71.7. Lee AG. The new competencies and their impact on residenttraining in ophthalmology. Surv Ophthalmol. 2003;48(6):651-62. Review.8. An update on the accreditation of graduate education inophthalmology. The Residency Review Committee for Ophthalmology.Arch Ophthalmol. 1987;105(9):1189-94.9. Zhou AW, Noble J, Lam WC. Canadian ophthalmology residencytraining: an evaluation of resident satisfaction andcomparison with international standards. Can J Ophthalmol.2009;44(5):540-7.10. Conselho Brasileiro de Oftalmologia. Quem somos. [citado2010 Ago 30]. Disponível em: http://www.cbo.com.br/novo/medicos/institucional/quem-somos11. Waisberg Y, Beniz Neto J. Considerações sobre a pósgraduaçãoem oftalmologia no Brasil. Rev Bras Oftalmol.1984;43(6):211-8.12. Gogate P, Deshpande M, Dharmadhikari S. Which is the bestmethod to learn ophthalmology? Resident doctors´ perspectiveof ophthalmology training. Indian J Ophthalmol.2008;56(5):409-12.13. Lee AG, Koch DD. A standardized curriculum and evaluationsystem for an ophthalmology residency. Acad Med.1998;73(5):447-8. Comment on Acad Med. 1997;72(7):564.14. Delgado AC, Sena M, Corbera JC, Ventura LO. Perfil de 80pós-graduandos em oftalmologia do Estado de Pernambuco,de 1998 a 2001. Rev Bras Oftalmol. 2002;61(3):204-9.15. Urbano RV, Ventura LM, Miller MT, Brandt CT, Ventura B,Miller LM. Formação de oftalmopediatras no Brasil. An FacMed Univ Fed Pernamb. 2005;50(2):119-21.16. Kohnen T. The value of surveys for cataract and refractivesurgery. J Cataract Refract Surg. 2003;29(9):1647-8.17. Brasil. Ministério da Educação. Sistema CNRM. Instituições xprogramas x vagas. Disponível em: http://mecsrv04.mec.gov.br/sesu/18. Instituto Brasileiro de Geografia e Estatística - IBGE. Vocêsabia? Curiosidades. Disponível em: http://www.ibge.gov.br/7a12/voce_sabia/curiosidades/curiosidade.php?id_curiosidade=11419. Conselho Brasileiro de Oftalmologia. Censo 2001: distribuiçãodos oftalmologistas por estado. São Paulo: CBO; 2001.20. Accreditation Council for Graduate Medical Education. OphthalmologyResident Operative Minimum Requirements.Available from: http://acgme.org/acWebsite/RRC_240/240_MinimumsOperativeTable.pdf21. Brasil. Conselho Federal de Medicina. Resolução CFM nº1785/2006, de 5 de abril de 2006. Dispõe sobre a nova redaçãodo Anexo II da Resolução DFM nº 1763/05 que celebra oconvênio de reconhecimento de especialidades médicasfirmado entre o Conselho Federal de Medicina (CFM), aAssociação Médica Brasileira (AMB) e a Comissão Nacionalde Residência Médica (CNRM). Disponível em: http://www.portalmedico.org.br/resolucoes/cfm/2006/1785_2006.htm.Endereço para Correspondência:Fundação Altino Ventura – FAVRua da Soledade, nº 170, Boa VistaCEP 50070-040 - Recife (PE), BrasilFone: (81)3302-4300E-mail: fav@fundacaoaltinoventura.org.brcamilaventura@hotmail.comRev Bras Oftalmol. 2012; 71 (3): 173-9
180ARTIGO ORIGINALPeriocular basal cell carcinoma: costof topical immunotherapy versusestimated cost of surgical treatmentCarcinoma basocelular periocular: custo da imunoterapiatópica versus custo estimado do tratamento cirúrgicoErick Marcet Santiago de Macedo 1 , Rachel Camargo Carneiro 1 , Pedro Carlos Carricondo 2 , Suzana Matayoshi 3ABSTRACTPurpose: The objective of this study was to compare the estimated cost of clinical and surgical treatment for basl cellcarcinoma of the eyelid. Methods: This was a pilot study of 12 patients with basal cell carcinoma receiving treatmentwith 5% imiquimod cream at the ocular plastic surgery center, medical school University of São Paulo (HC-FMUSP,Brazil). The cost of clinical treatment was estimated based on the time of treatment and amount of medicationconsumed by patients in the home setting. The cost of surgical treatment was estimated by ophthalmologists withexperience in reconstructive plastic surgery based on analysis of images of the same patients. Surgeons responded toa questionnaire with four questions about surgical technique, surgical materials required, estimated duration ofsurgery and type of anesthesia.Results: Immunotherapy lasted from 8 to 12 weeks. All patients reported each coldstoredsachet with 5% imiquimod cream lasted 3 days. According to the institution, a box with 12 sachets costs BRL480.00. Patients required 1.58-3.11 boxes for complete treatment, corresponding to a total cost of BRL 758.40-1,492.80. Based on image analysis, surgeons evaluated surgery would require 1-3 hours. The estimated cost ofsurgery room and staff was BRL 263.00, to which the cost of supplies was added. Thus, the total cost of surgicaltreatment was BRL 272.61-864.82. On the average, immunotherapy was 57,64% more costly than surgical treatment.Conclusions: Malignant eyelid tumors are a common finding in clinical ophthalmology. Surgery is still the treatmentof choice at our institution, but immunotherapy with 5% imiquimod cream may be indicated for patients withmultiple lesions or high surgical risk and for patients declining surgery for reasons of fear or esthetic concerns. Theability to estimate costs related to the treatment of malignant eyelid tumors is an important aid in the financialplanning of health care institutions. Further studies should evaluate the possibility of institutions equating the cost ofimmunotherapy and surgical treatment by acquiring similar but less expensive medications.Keywords: Carcinoma, basal cell carcinoma/surgery; Carcinoma, basal cell /economy; Carcinoma, basal cellcarcinoma/drug therapy; Eyelid neoplasms; Antineoplastic agents/therapeutic use; Biopsy; Health care costs1Department of Ophthalmology, Hospital das Clínicas, Medical School, Universidade de São Paulo (USP) - São Paulo (SP), Brazil;2Department of Ophthalmology, Hospital das Clínicas, Medical School, Universidade de São Paulo (USP) - São Paulo (SP), Brazil;3Department of Ophthalmology, Hospital das Clínicas, Medical School, Universidade de São Paulo (USP) - São Paulo (SP), Brazil;Study conducted at the Ocular Plastic Surgery Center, Department of Ophthalmology, Hospital das Clínicas, Medical School,Universidade de São Paulo (USP) - São Paulo (SP), Brazil.Clinical Trials.gov Identifier: NCT00803907Apoio do CNPq - processo n° 480144/2008-7Os autores declaram inexistir conflitos de interesseRecebido para publicação em 2/11/2011 - Aceito para publicação em 2/3/2011Rev Bras Oftalmol. 2012; 71 (3): 180-3
Page 1 and 2: vol. 71 - nº 3 - Maio/Junho 2012RB
Page 3 and 4: 144Revista Brasileira de Oftalmolog
Page 5 and 6: 146173 Características e deficiên
Page 7 and 8: 148Rezende F, Bisol RAR, Tiago Biso
Page 9 and 10: 150Ventura BV, Ventura M, Lira W, V
Page 15 and 16: 156Moura EM, Volpini M, Moura GAGIN
Page 17 and 18: 158Moura EM, Volpini M, Moura GAGco
Page 19 and 20: 160ARTIGO ORIGINALEficácia da comb
Page 21 and 22: 162Almodin J, Buhler Junior C, Almo
Page 23 and 24: 164ARTIGO ORIGINALHipermetropia ap
Page 25 and 26: 166Ambrósio Jr R, Silva RS; Lopes
Page 33 and 34: 174Ventura CVOC, Gomes MLS, Ventura
Page 35 and 36: 176Ventura CVOC, Gomes MLS, Ventura
Page 37: 178Ventura CVOC, Gomes MLS, Ventura
Page 41 and 42: 182Macedo EMS, Carneiro RC, Carrico
Page 43 and 44: 184RELATO DE CASODiplopia após inj
Page 45 and 46: 186Rassi MMO, Santos LHBTABELA 1Per
Page 47 and 48: 188RELATO DE CASOSíndrome de Down:
Page 49 and 50: 190Lorena SHTachados de blefarite e
Page 51 and 52: 192Passos AF, Borges DFINTRODUÇÃO
Page 53 and 54: 194ARTIGO DE REVISÃOImportance of
Page 55 and 56: 196Veloso CER, Almeida LNF, De Marc
Page 57 and 58: 198Veloso CER, Almeida LNF, De Marc
Page 59 and 60: 200Schellini SA, Sousa RLFINTRODUÇ
Page 61 and 62: 202Schellini SA, Sousa RLFduzidos m
Page 63 and 64: 204Schellini SA, Sousa RLF18. Ferra
Page 65 and 66: 206Instruções aos autoresA Revist
Page 67: 208RevistaBrasileira deOftalmologia

Mai-Jun - Sociedade Brasileira de Oftalmologia

Create successful ePaper yourself

Delete template?

Save as template?